Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

The new school was designed by working with national industry leaders who examined the needs in public health.

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor ...

Civil society groups, including scientists and human rights advocates, are raising their voices. Organizations like the Campaign to Stop Killer Robots are leading the charge, urging nations to ban ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

IV Maintenance Dosing for the treatment of Early Alzheimer's Disease Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease ...

Oil and gas production in the United States is hitting record highs, easily outpacing consumption growth and fueling an export boom that in 2020 achieved the country’s first trade surplus in energy ...

Last week, the Department of Medicine launched its 2025 Leadership DOM cohort. Dr. Julie McDonald of McDonald Graham, LLC, and Stacy Buford, MSA, DOM Director of Strategic Operations, welcomed the ...

Risk of proteinuria with atezolizumab plus bevacizumab versus lenvatinib in first-line systemic treatment for hepatocellular carcinoma. End-of-life (EOL) outcomes and healthcare utilization for ...

This cohort study showed that, during the 2022 to 2023 season, infection with SARS-CoV-2 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV), whereas ...

Australia 2 School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia Objective To determine whether Olympic medallists live longer than the general population.